Big Pharma’s Ails Could Spread To Biotech It is no secret big drugmakers are sick. Investors should worry that their […]

Financial Snapshot For December Financial Snapshot For December 2004: Sideways

Facing Biotech Foods Without the Fear Factor “Almost everywhere food is sold these days, you are likely to find products

Big Changes for Big Pharma Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are

Biotechs forced to work harder to fill openings: Bay Area biotech companies are scrambling to attract and retain both researchers

Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on

Survey Shows Lack of Confidence at FDA About two-thirds of Food and Drug Administration scientists are less than fully confident

Bill Aims to Protect Joint Patents Patents that result from collaboration between universities and companies won new protections from legal

Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international

The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late